(Q42144353)

English

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

scientific article published on 18 July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor (English)

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

chemoradiotherapy

0 references

author name string

Hoebers FJ

1

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Pluim D

2

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Hart AA

3

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Verheij M

4

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Balm AJ

5

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Fons G

6

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Rasch CR

7

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Schellens JH

8

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Stalpers LJ

9

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Bartelink H

10

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Begg AC

11

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

publication date

18 July 2007

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

61

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

6

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

1075-1081

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

https://scigraph.springernature.com/pub.10.1007/s00280-007-0545-1

0 references

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Molecular profiling of platinum resistant ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

32P-postlabeling assay for the quantification of the major platinum-DNA adducts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Comparison of intra-arterial and intravenous infusion of cisplatin for head and neck squamous cell carcinoma in a modified rat model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Increased cisplatin tissue levels with prolonged arterial infusion in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

29 May 2018

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

17 August 2018

Cisplatin- and carboplatin-DNA adducts: is Pt-AG the cytotoxic lesion?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

17 August 2018

Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

17 August 2018

The measurement of cisplatin-DNA adduct levels in testicular cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2270367

17 August 2018

Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization by cisplatin of RIF1 tumour cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the pharmacological benefit and determination of the influencing factors of intraarterial cis-diamminedichloroplatinum administration in patients with uterine cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between patient response in ovarian and breast cancer and platinum drug-DNA adduct formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17639394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00280-007-0545-1

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42144353&oldid=1934606776"